• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症的能量学

The energetics of Huntington's disease.

作者信息

Browne Susan E, Beal M Flint

机构信息

Department of Neurology and Neuroscience, A-502, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York 10021, USA.

出版信息

Neurochem Res. 2004 Mar;29(3):531-46. doi: 10.1023/b:nere.0000014824.04728.dd.

DOI:10.1023/b:nere.0000014824.04728.dd
PMID:15038601
Abstract

Huntington's disease (HD) is a hereditary neurodegenerative disorder that gradually robs sufferers of the ability to control movements and induces psychological and cognitive impairments. This devastating, lethal disease is one of several neurological disorders caused by trinucleotide expansions in affected genes, including spinocerebellar ataxias, dentatorubral-pallidoluysian atrophy, and spinal bulbar muscular atrophy. HD symptoms are associated with region-specific neuronal loss within the central nervous system, but to date the mechanism of this selective cell death remains unknown. Strong evidence from studies in humans and animal models suggests the involvement of energy metabolism defects, which may contribute to excitotoxic processes, oxidative dmage, and altered gene regulation. The development of transgenic mouse models expressing the human HD mutation has provided novel opportunities to explore events underlying selective neuronal death in HD, which has hitherto been impossible in humans. Here we discuss how animal models are redefining the role of energy metabolism in HD etiology.

摘要

亨廷顿舞蹈症(HD)是一种遗传性神经退行性疾病,它会逐渐剥夺患者控制运动的能力,并引发心理和认知障碍。这种具有毁灭性的致命疾病是由受影响基因中的三核苷酸重复扩增引起的几种神经疾病之一,包括脊髓小脑共济失调、齿状核红核苍白球路易体萎缩症和脊髓延髓肌肉萎缩症。HD症状与中枢神经系统内特定区域的神经元丢失有关,但迄今为止,这种选择性细胞死亡的机制仍不清楚。来自人类和动物模型研究的有力证据表明能量代谢缺陷与之相关,这可能导致兴奋毒性过程、氧化损伤和基因调控改变。表达人类HD突变的转基因小鼠模型的开发为探索HD中选择性神经元死亡背后的事件提供了新机会,而这在人类中迄今为止是不可能实现的。在此,我们讨论动物模型如何重新定义能量代谢在HD病因学中的作用。

相似文献

1
The energetics of Huntington's disease.亨廷顿舞蹈症的能量学
Neurochem Res. 2004 Mar;29(3):531-46. doi: 10.1023/b:nere.0000014824.04728.dd.
2
Oxidative damage in Huntington's disease pathogenesis.亨廷顿舞蹈病发病机制中的氧化损伤
Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2061-73. doi: 10.1089/ars.2006.8.2061.
3
Bioenergetics in Huntington's disease.亨廷顿舞蹈病中的生物能量学
Ann N Y Acad Sci. 1999;893:203-13. doi: 10.1111/j.1749-6632.1999.tb07827.x.
4
Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?大脑中的葡萄糖转运及其在亨廷顿病中的损伤:能量代谢衰竭的又一表现?
Amino Acids. 2017 Jul;49(7):1147-1157. doi: 10.1007/s00726-017-2417-2. Epub 2017 Apr 10.
5
Oxidative stress in Huntington's disease.亨廷顿舞蹈症中的氧化应激
Brain Pathol. 1999 Jan;9(1):147-63. doi: 10.1111/j.1750-3639.1999.tb00216.x.
6
Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.线粒体与亨廷顿舞蹈症发病机制:来自遗传和化学模型的见解
Ann N Y Acad Sci. 2008 Dec;1147:358-82. doi: 10.1196/annals.1427.018.
7
Inhibitors of metabolism rescue cell death in Huntington's disease models.代谢抑制剂可挽救亨廷顿舞蹈症模型中的细胞死亡。
Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14525-30. doi: 10.1073/pnas.0704482104. Epub 2007 Aug 28.
8
[The role of mitochondria in the pathogenesis of Huntington's disease].[线粒体在亨廷顿舞蹈病发病机制中的作用]
Postepy Biochem. 2010;56(2):174-81.
9
Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations.蛋白质聚集与亨廷顿舞蹈症的发病机制:机制及相关性
Biol Chem. 2000 Sep-Oct;381(9-10):937-42. doi: 10.1515/BC.2000.114.
10
Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.脑尿素增加是在先兆转基因绵羊模型和 HD 病例中观察到的亨廷顿病早期发病事件。
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11293-E11302. doi: 10.1073/pnas.1711243115. Epub 2017 Dec 11.

引用本文的文献

1
Mitochondrial Dysfunction in Neurodegenerative Diseases.神经退行性疾病中的线粒体功能障碍
Cells. 2025 Feb 13;14(4):276. doi: 10.3390/cells14040276.
2
ATAD1 Regulates Neuronal Development and Synapse Formation Through Tuning Mitochondrial Function.ATAD1通过调节线粒体功能来调控神经元发育和突触形成。
Int J Mol Sci. 2024 Dec 24;26(1):44. doi: 10.3390/ijms26010044.
3
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.探讨亨廷顿病的分子机制、治疗策略和临床表现。

本文引用的文献

1
Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy.升高的细胞内葡萄糖浓度通过降低mTOR磷酸化和诱导自噬来减少由突变亨廷顿蛋白外显子1引起的聚集和细胞死亡。
Hum Mol Genet. 2003 May 1;12(9):985-94. doi: 10.1093/hmg/ddg109.
2
Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease.甘油醛-3-磷酸脱氢酶在亨廷顿舞蹈病转基因小鼠模型中的过表达与核内蓄积
Mol Cell Neurosci. 2003 Mar;22(3):285-97. doi: 10.1016/s1044-7431(02)00013-1.
3
Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w. Epub 2024 May 19.
4
Neuropathogenesis-on-chips for neurodegenerative diseases.神经退行性疾病的类脑芯片研究进展
Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8.
5
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.亨廷顿舞蹈病中的细胞重排与氧化/抗氧化失衡
Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571.
6
Vitamin B B and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease.维生素B和叶酸调节亨廷顿病酵母模型中失调的信号通路和蛋白质聚集。
3 Biotech. 2023 Mar;13(3):96. doi: 10.1007/s13205-023-03525-y. Epub 2023 Feb 24.
7
Modulation of Synaptic Plasticity Genes Associated to DNA Damage in a Model of Huntington's Disease.调节与亨廷顿病模型中 DNA 损伤相关的突触可塑性基因。
Neurochem Res. 2023 Jul;48(7):2093-2103. doi: 10.1007/s11064-023-03889-w. Epub 2023 Feb 15.
8
Microneedles: A Versatile Drug Delivery Carrier for Phytobioactive Compounds as a Therapeutic Modulator for Targeting Mitochondrial Dysfunction in the Management of Neurodegenerative Diseases.微针:一种多功能药物输送载体,用于植物生物活性化合物,作为治疗调节剂,针对神经退行性疾病中线粒体功能障碍的靶向治疗。
Curr Neuropharmacol. 2024;22(6):1110-1128. doi: 10.2174/1570159X20666221012142247.
9
The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington's Disease Model by Acting on the Expression of Carnitine-Related Genes.肉碱棕榈酰转移酶 1 抑制剂(替格列净)通过作用于肉碱相关基因的表达改善果蝇亨廷顿病模型的神经退行性表型。
Molecules. 2022 May 13;27(10):3125. doi: 10.3390/molecules27103125.
10
Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).神经疾病的免疫基因网络:多发性硬化症(MS)、阿尔茨海默病(AD)、帕金森病(PD)和亨廷顿病(HD)。
Heliyon. 2021 Dec 1;7(12):e08518. doi: 10.1016/j.heliyon.2021.e08518. eCollection 2021 Dec.
Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
突变亨廷顿蛋白在患有亨廷顿舞蹈症的小鼠中引发情境依赖性神经退行性变。
J Neurosci. 2003 Mar 15;23(6):2193-202. doi: 10.1523/JNEUROSCI.23-06-02193.2003.
4
Apoptosis in Huntington's disease.亨廷顿舞蹈病中的细胞凋亡
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):255-65. doi: 10.1016/S0278-5846(03)00021-6.
5
Transgenic rat model of Huntington's disease.亨廷顿舞蹈病转基因大鼠模型
Hum Mol Genet. 2003 Mar 15;12(6):617-24. doi: 10.1093/hmg/ddg075.
6
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.饮食限制可使亨廷顿蛋白突变小鼠的葡萄糖代谢和脑源性神经营养因子(BDNF)水平正常化,减缓疾病进展,并延长生存期。
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2911-6. doi: 10.1073/pnas.0536856100. Epub 2003 Feb 14.
7
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.特定的渐进性环磷酸腺苷(cAMP)减少表明症状前亨廷顿舞蹈症基因敲入小鼠存在能量不足。
Hum Mol Genet. 2003 Mar 1;12(5):497-508. doi: 10.1093/hmg/ddg046.
8
Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.亨廷顿舞蹈症小鼠模型中皮质纹状体通路的短暂性和进行性电生理改变
J Neurosci. 2003 Feb 1;23(3):961-9. doi: 10.1523/JNEUROSCI.23-03-00961.2003.
9
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease.聚谷氨酰胺序列对大鼠和人类线粒体钙依赖性去极化的体外影响:与亨廷顿舞蹈病的相关性
Arch Biochem Biophys. 2003 Feb 1;410(1):1-6. doi: 10.1016/s0003-9861(02)00585-4.
10
Toxin-induced mitochondrial dysfunction.毒素诱导的线粒体功能障碍。
Int Rev Neurobiol. 2002;53:243-79. doi: 10.1016/s0074-7742(02)53010-5.